---
figid: PMC7161552__BPH-177-2024-g010
figtitle: Modeling Neoadjuvant chemotherapy resistance in vitro increased NRP‐1 and
  HER2 expression and converted MCF7 breast cancer subtype
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC7161552
filename: BPH-177-2024-g010.jpg
figlink: /pmc/articles/PMC7161552/figure/bph14966-fig-0010/
number: F10
caption: In vitro modelling of neoadjuvant chemotherapy (NAC) resistance revealed
  different pathways of resistance in MDA‐MB‐231 and MCF7 cells. (a) Resistant MDA‐MB‐231
  cells activated NRP‐1/integrin β3/FAK/NF‐κBp65 but down‐regulated BCRP/ABCG2. On
  the other hand, (b) MCF7 cells resistant to 4xAC overexpressed NRP‐1 and ER‐α and
  induced EGFR expression and phosphorylation, which consequently activated the FAK/PI3K/AKT/NF‐κBp65pathway,
  in addition to increasing ER‐α, EGFR2, HER‐2, and TNFR2. (c) Additional paclitaxel
  cycles in MCF7 cells (4xAC + 4xPAC0 up‐regulated BCRP/ABCG2 in response to the increase
  in cyclin B1 and deactivated the FAK/PI3K/AKT/NF‐κBp65signalling pathway
papertitle: Modeling Neoadjuvant chemotherapy resistance in vitro increased NRP‐1
  and HER2 expression and converted MCF7 breast cancer subtype.
reftext: Noura Al‐Zeheimi, et al. Br J Pharmacol. 2020 May;177(9):2024-2041.
year: '2020'
doi: 10.1111/bph.14966
journal_title: British Journal of Pharmacology
journal_nlm_ta: Br J Pharmacol
publisher_name: John Wiley and Sons Inc.
keywords: ''
automl_pathway: 0.6599746
figid_alias: PMC7161552__F10
figtype: Figure
redirect_from: /figures/PMC7161552__F10
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7161552__BPH-177-2024-g010.html
  '@type': Dataset
  description: In vitro modelling of neoadjuvant chemotherapy (NAC) resistance revealed
    different pathways of resistance in MDA‐MB‐231 and MCF7 cells. (a) Resistant MDA‐MB‐231
    cells activated NRP‐1/integrin β3/FAK/NF‐κBp65 but down‐regulated BCRP/ABCG2.
    On the other hand, (b) MCF7 cells resistant to 4xAC overexpressed NRP‐1 and ER‐α
    and induced EGFR expression and phosphorylation, which consequently activated
    the FAK/PI3K/AKT/NF‐κBp65pathway, in addition to increasing ER‐α, EGFR2, HER‐2,
    and TNFR2. (c) Additional paclitaxel cycles in MCF7 cells (4xAC + 4xPAC0 up‐regulated
    BCRP/ABCG2 in response to the increase in cyclin B1 and deactivated the FAK/PI3K/AKT/NF‐κBp65signalling
    pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - scb
  - Egfr
  - Fak
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - br
  - Pten
  - era
  - bo
  - bod
  - HDAC4
  - egh
  - LanB1
  - betaTub56D
  - mys
  - Prosbeta1
  - ERBB2
  - GNPTAB
  - EGFR
  - PTK2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - NRP1
  - NELL1
  - ABCG2
  - PTEN
  - TNFRSF1B
  - ESR1
  - ERAL1
  - BCL2L11
  - ATP6V1B2
  - B3GNT2
  - B3GNTL1
  - CCNB1
---
